SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 209.89 |
Enterprise Value ($M) | 200.73 |
Book Value ($M) | 31.15 |
Book Value / Share | 2.88 |
Price / Book | 6.74 |
NCAV ($M) | 9.82 |
NCAV / Share | 0.91 |
Price / NCAV | 21.37 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.79 |
Return on Assets (ROA) | -0.48 |
Return on Equity (ROE) | -1.30 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.86 |
Current Ratio | 1.97 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 52.16 |
Assets | 73.50 |
Liabilities | 42.34 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 20.22 |
Operating Income | -19.40 |
Net Income | -30.22 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -13.62 |
Cash from Investing | -8.40 |
Cash from Financing | 19.39 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Point72 Asset Management, L.P. | 0.10 | -98.57 | |
13G/A | Rosalind Advisors, Inc. | 5.80 | 22.31 | |
13G | Yelin Lapidot Holdings Management Ltd. | 6.96 | 96.55 | |
13D/A | Access Industries Holdings LLC | 13.80 | ||
13D | Molnlycke Health Care AB | 8.10 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
17,632 | 80,527 | 21.90 | |
61,799 | 377,989 | 16.35 | |
23,547 | 118,685 | 19.84 | |
11,479 | 25,001 | 45.91 | |
(click for more detail) |
Similar Companies | |
---|---|
LNTH – Lantheus Holdings, Inc. | LRMR – Larimar Therapeutics, Inc. |
LXEO – Lexeo Therapeutics, Inc. | MIRM – Mirum Pharmaceuticals, Inc. |
MNKD – MannKind Corporation |
Financial data and stock pages provided by
Fintel.io